(VVX) V2X - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92242T1016
Stock: Defense, Logistics, Aerospace, Training, Technology
Total Rating 45
Risk 75
Buy Signal -0.31
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 43.2% |
| Relative Tail Risk | -18.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | 11.75 |
| Character TTM | |
|---|---|
| Beta | 0.863 |
| Beta Downside | 0.932 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.90% |
| CAGR/Max DD | 0.35 |
Description: VVX V2X January 16, 2026
V2X, Inc. (NYSE:VVX) delivers mission-critical solutions and support services to defense customers worldwide, spanning operations & logistics, aerospace, training, and technology for national security, civilian, and international clients. The company, incorporated in 2014 and based in Reston, Virginia, operates as a subsidiary of Vertex Aerospace Holdco LLC.
Key performance indicators that analysts watch include the company’s backlog-currently around $1.2 billion, reflecting multi-year contracts with the U.S. Department of Defense-and its operating margin, which has hovered near 12% in the most recent quarters, outperforming the broader Aerospace & Defense (A&D) sector average of roughly 9% due to higher contract labor utilization. Additionally, V2X’s revenue growth is closely tied to U.S. defense spending trends; the FY2024 defense budget is projected to rise ~3% YoY, providing a favorable macro backdrop for contract wins.
For a deeper dive into V2X’s valuation metrics and how they compare to peers, consider exploring the ValueRay platform’s detailed analyst models.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 80.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 3.75 > 1.0 |
| NWC/Revenue: 4.17% < 20% (prev 1.81%; Δ 2.36% < -1%) |
| CFO/TA 0.06 > 3% & CFO 195.7m > Net Income 80.1m |
| Net Debt (960.0m) to EBITDA (294.9m): 3.26 < 3 |
| Current Ratio: 1.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.9m) vs 12m ago -0.37% < -2% |
| Gross Margin: 8.50% > 18% (prev 0.08%; Δ 842.4% > 0.5%) |
| Asset Turnover: 140.2% > 50% (prev 134.5%; Δ 5.70% > 0%) |
| Interest Coverage Ratio: 2.15 > 6 (EBITDA TTM 294.9m / Interest Expense TTM 85.5m) |
Altman Z'' 1.26
| A: 0.06 (Total Current Assets 1.10b - Total Current Liabilities 914.3m) / Total Assets 3.18b |
| B: 0.10 (Retained Earnings 320.6m / Total Assets 3.18b) |
| C: 0.06 (EBIT TTM 184.1m / Avg Total Assets 3.15b) |
| D: 0.15 (Book Value of Equity 313.3m / Total Liabilities 2.10b) |
| Altman-Z'' Score: 1.26 = BB |
Beneish M -3.16
| DSRI: 0.94 (Receivables 759.4m/766.4m, Revenue 4.42b/4.20b) |
| GMI: 0.93 (GM 8.50% / 7.93%) |
| AQI: 0.95 (AQ_t 0.62 / AQ_t-1 0.65) |
| SGI: 1.05 (Revenue 4.42b / 4.20b) |
| TATA: -0.04 (NI 80.1m - CFO 195.7m) / TA 3.18b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of VVX shares?
As of February 06, 2026, the stock is trading at USD 63.98 with a total of 375,213 shares traded.
Over the past week, the price has changed by -6.45%, over one month by +6.78%, over three months by +13.74% and over the past year by +23.37%.
Over the past week, the price has changed by -6.45%, over one month by +6.78%, over three months by +13.74% and over the past year by +23.37%.
Is VVX a buy, sell or hold?
V2X has received a consensus analysts rating of 3.82.
Therefore, it is recommended to buy VVX.
- StrongBuy: 5
- Buy: 2
- Hold: 2
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the VVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.8 | 6% |
| Analysts Target Price | 67.8 | 6% |
| ValueRay Target Price | 70.7 | 10.5% |
VVX Fundamental Data Overview February 03, 2026
P/E Trailing = 27.2055
P/E Forward = 12.1655
P/S = 0.4855
P/B = 1.9745
Revenue TTM = 4.42b USD
EBIT TTM = 184.1m USD
EBITDA TTM = 294.9m USD
Long Term Debt = 1.09b USD (from longTermDebt, last quarter)
Short Term Debt = 15.0m USD (from shortTermDebt, last quarter)
Debt = 1.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 960.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (2.15b + Debt 1.14b - CCE 179.3m)
Interest Coverage Ratio = 2.15 (Ebit TTM 184.1m / Interest Expense TTM 85.5m)
EV/FCF = 16.80x (Enterprise Value 3.11b / FCF TTM 184.9m)
FCF Yield = 5.95% (FCF TTM 184.9m / Enterprise Value 3.11b)
FCF Margin = 4.18% (FCF TTM 184.9m / Revenue TTM 4.42b)
Net Margin = 1.81% (Net Income TTM 80.1m / Revenue TTM 4.42b)
Gross Margin = 8.50% ((Revenue TTM 4.42b - Cost of Revenue TTM 4.04b) / Revenue TTM)
Gross Margin QoQ = 8.10% (prev 8.88%)
Tobins Q-Ratio = 0.98 (Enterprise Value 3.11b / Total Assets 3.18b)
Interest Expense / Debt = 1.75% (Interest Expense 20.0m / Debt 1.14b)
Taxrate = 24.86% (8.14m / 32.7m)
NOPAT = 138.3m (EBIT 184.1m * (1 - 24.86%))
Current Ratio = 1.20 (Total Current Assets 1.10b / Total Current Liabilities 914.3m)
Debt / Equity = 1.06 (Debt 1.14b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 3.26 (Net Debt 960.0m / EBITDA 294.9m)
Debt / FCF = 5.19 (Net Debt 960.0m / FCF TTM 184.9m)
Total Stockholder Equity = 1.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.54% (Net Income 80.1m / Total Assets 3.18b)
RoE = 7.62% (Net Income TTM 80.1m / Total Stockholder Equity 1.05b)
RoCE = 8.60% (EBIT 184.1m / Capital Employed (Equity 1.05b + L.T.Debt 1.09b))
RoIC = 6.41% (NOPAT 138.3m / Invested Capital 2.16b)
WACC = 6.39% (E(2.15b)/V(3.28b) * Re(9.08%) + D(1.14b)/V(3.28b) * Rd(1.75%) * (1-Tc(0.25)))
Discount Rate = 9.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.66%
[DCF Debug] Terminal Value 86.71% ; FCFF base≈136.8m ; Y1≈168.8m ; Y5≈287.5m
Fair Price DCF = 199.5 (EV 7.18b - Net Debt 960.0m = Equity 6.22b / Shares 31.2m; r=6.39% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 47.31 | EPS CAGR: -8.51% | SUE: -3.83 | # QB: 0
Revenue Correlation: 77.58 | Revenue CAGR: 31.38% | SUE: 1.34 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.13 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=5.67 | Chg30d=-0.011 | Revisions Net=-1 | Growth EPS=+12.9% | Growth Revenue=+5.2%
P/E Forward = 12.1655
P/S = 0.4855
P/B = 1.9745
Revenue TTM = 4.42b USD
EBIT TTM = 184.1m USD
EBITDA TTM = 294.9m USD
Long Term Debt = 1.09b USD (from longTermDebt, last quarter)
Short Term Debt = 15.0m USD (from shortTermDebt, last quarter)
Debt = 1.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 960.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (2.15b + Debt 1.14b - CCE 179.3m)
Interest Coverage Ratio = 2.15 (Ebit TTM 184.1m / Interest Expense TTM 85.5m)
EV/FCF = 16.80x (Enterprise Value 3.11b / FCF TTM 184.9m)
FCF Yield = 5.95% (FCF TTM 184.9m / Enterprise Value 3.11b)
FCF Margin = 4.18% (FCF TTM 184.9m / Revenue TTM 4.42b)
Net Margin = 1.81% (Net Income TTM 80.1m / Revenue TTM 4.42b)
Gross Margin = 8.50% ((Revenue TTM 4.42b - Cost of Revenue TTM 4.04b) / Revenue TTM)
Gross Margin QoQ = 8.10% (prev 8.88%)
Tobins Q-Ratio = 0.98 (Enterprise Value 3.11b / Total Assets 3.18b)
Interest Expense / Debt = 1.75% (Interest Expense 20.0m / Debt 1.14b)
Taxrate = 24.86% (8.14m / 32.7m)
NOPAT = 138.3m (EBIT 184.1m * (1 - 24.86%))
Current Ratio = 1.20 (Total Current Assets 1.10b / Total Current Liabilities 914.3m)
Debt / Equity = 1.06 (Debt 1.14b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 3.26 (Net Debt 960.0m / EBITDA 294.9m)
Debt / FCF = 5.19 (Net Debt 960.0m / FCF TTM 184.9m)
Total Stockholder Equity = 1.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.54% (Net Income 80.1m / Total Assets 3.18b)
RoE = 7.62% (Net Income TTM 80.1m / Total Stockholder Equity 1.05b)
RoCE = 8.60% (EBIT 184.1m / Capital Employed (Equity 1.05b + L.T.Debt 1.09b))
RoIC = 6.41% (NOPAT 138.3m / Invested Capital 2.16b)
WACC = 6.39% (E(2.15b)/V(3.28b) * Re(9.08%) + D(1.14b)/V(3.28b) * Rd(1.75%) * (1-Tc(0.25)))
Discount Rate = 9.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.66%
[DCF Debug] Terminal Value 86.71% ; FCFF base≈136.8m ; Y1≈168.8m ; Y5≈287.5m
Fair Price DCF = 199.5 (EV 7.18b - Net Debt 960.0m = Equity 6.22b / Shares 31.2m; r=6.39% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 47.31 | EPS CAGR: -8.51% | SUE: -3.83 | # QB: 0
Revenue Correlation: 77.58 | Revenue CAGR: 31.38% | SUE: 1.34 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.13 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=5.67 | Chg30d=-0.011 | Revisions Net=-1 | Growth EPS=+12.9% | Growth Revenue=+5.2%